KETO-CTA was deadly. Average (median) participant experienced 50% increase in non-calcified plaque volume year over year.

KETO-CTA's preregistered primary outcome was missing from the paper, says Dr Albert
Shares Dr Albert's critique that KETO-CTA preregistered percent change in non-calcified plaque volume but did not report it in the paper. He also cites a one-year increase of 18.8 mm3, short follow-up, no control arm and misapplied historical controls.


